rs371201410
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_004070.4(CLCNKA):c.8A>C(p.Glu3Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000895 in 1,564,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004070.4 missense
Scores
Clinical Significance
Conservation
Publications
- Bartter disease type 4BInheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
- Bartter syndrome type 4Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKA | NM_004070.4 | c.8A>C | p.Glu3Ala | missense_variant | Exon 2 of 20 | ENST00000331433.5 | NP_004061.3 | |
CLCNKA | NM_001042704.2 | c.8A>C | p.Glu3Ala | missense_variant | Exon 2 of 20 | NP_001036169.1 | ||
CLCNKA | NM_001257139.2 | c.8A>C | p.Glu3Ala | missense_variant | Exon 2 of 19 | NP_001244068.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151956Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000568 AC: 1AN: 176006 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000921 AC: 13AN: 1412124Hom.: 0 Cov.: 30 AF XY: 0.00000430 AC XY: 3AN XY: 697806 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151956Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74224 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.8A>C (p.E3A) alteration is located in exon 2 (coding exon 1) of the CLCNKA gene. This alteration results from a A to C substitution at nucleotide position 8, causing the glutamic acid (E) at amino acid position 3 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at